Clin2
NCT06463678Possibly a fitNot yet recruiting

Investigational eye drop for fungal keratitis

Fungal Keratitis

Part of Eyes & vision, Infections clinical trials.

This study tests an investigational new eye drop called IVIEW-1201 for treating fungal keratitis, a fungal infection of the cornea. It aims to see if it is safe and effective compared to standard treatment, which could help clear the infection and protect your vision.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
60 people
Ages
15 years and older
Study type
Interventional

Who can take part

  • You are 15 years old or older.
  • A doctor has diagnosed you with fungal keratitis (a fungal infection of the cornea), and it is confirmed by a lab test.
  • You have not used antifungal eye drops or ointments in the last 48 hours.
  • You are willing to follow the study schedule and attend all appointments.
  • You do not have severe other eye problems like a cornea hole, glaucoma, or chemical burns.
  • You are not currently using certain medications like steroid eye drops or systemic antifungals.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06658002Recruiting· Phase 3
Testing stronger eye drops for fungal eye infections

This trial tests if adding cyclosporine A to the standard natamycin eye drops can better treat fungal eye infections. It may help people with moderate vision loss from a fungal corneal infection.

San Francisco, California
NCT07856680Not yet recruiting· Phase 4
Fungal eyelid treatment study

This study tests an antifungal eye drop called Natacyn for blepharitis, an eyelid inflammation that may be caused by fungus. Participants use the drops four times a day for three weeks to see if it clears the infection.

Jacksonville, Florida
NCT07568730Recruiting· Phase 2
Testing Lacripep eye drops for neurotrophic keratitis

This trial tests whether a new eye drop called Lacripep can help treat neurotrophic keratitis, a rare eye condition where the cornea loses sensation and can become damaged. The study compares Lacripep to a placebo (inactive) drop to see if it improves corneal healing and vision.

Tampa, Florida
NCT06360133Recruiting· Phase 3
New eye drop for dry eye disease

This study tests a new eye drop (5% VVN001) to treat dry eye disease that hasn't improved enough with artificial tears. It may help people with moderate-to-severe dry eye and low tear production.

Shanghai, Shanghai Municipality
NCT07743489Not yet recruiting· Phase 3
Light therapy for fungal eye infection

This study tests a new light-based treatment for a fungal eye infection called Fusarium keratitis. It aims to see if this therapy can help improve vision and clear the infection.

Palo Alto, California
NCT06364878Recruiting
Non-invasive diagnosis for eye infections

This study tests a new, non-invasive (no needles or surgery) way to diagnose a type of eye infection called microbial keratitis. It may help find the cause faster so you get the right treatment sooner.

Arendal

Hear when a new Fungal Keratitis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.